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A modular yeast biosensor for low-cost point-of-care
pathogen detection
Nili Ostrov,1*† Miguel Jimenez,1*‡ Sonja Billerbeck,1* James Brisbois,1 Joseph Matragrano,1
Alastair Ager,2,3 Virginia W. Cornish1,4§
The availability of simple, specific, and inexpensive on-site detection methods is of key importance for deploy-
ment of pathogen surveillance networks. We developed a nontechnical and highly specific colorimetric assay
for detection of pathogen-derived peptides based on Saccharomyces cerevisiae—a genetically tractable model
organism and household product. Integrating G protein–coupled receptors with a visible, reagent-free lycopene
readout, we demonstrate differential detection of major human, plant, and food fungal pathogens with nano-
molar sensitivity. We further optimized a one-step rapid dipstick prototype that can be used in complex
samples, including blood, urine, and soil. This modular biosensor can be economically produced at large scale,
is not reliant on cold-chain storage, can be detected without additional equipment, and is thus a compelling
platform scalable to global surveillance of pathogens.ow






Global surveillance of pathogens is critical for human health, food se-
curity, bioterrorism, and maintenance of biodiversity (1, 2). Although
monitoring of global pathogen burden has been traditionally limited to
a small number of specialized centers, more effective detection could be
performed in real time by making accurate diagnostics accessible at the
point of care (3). However, these tests are only available for a handful of
pathogens and often rely on costly reagents, cold-chain distribution,
specialized equipment, and technical personnel (4, 5). In the absence
of innovative alternatives to expensive antibody- andnucleic acid–based
assays, lengthy culturingmethods remain as the dominant approach for
monitoring pathogens in resource-limited areas (3).
The emerging field of synthetic biology has the potential to provide
novel diagnostic platforms to overcome global health challenges (6, 7),
much like advances in molecular biology gave rise to antibody diagnos-
tics. Although synthetic biology has thus far been leveraged primarily
for economical fermentation of industrial and biomedical commodities
via metabolic engineering (8), significant applications in public health,
animal health, and agriculture remain untapped.
Here,wedemonstrate that highly specialized Saccharomyces cerevisiae
cells can be generated to create transformative on-site diagnostic de-
vices unattainable via traditional engineering methods. Of the growing
number of engineered biological systems used for biosensing (7, 9–11),
S. cerevisiae stands out because of its marked robustness, genetic trac-
tability, and established human safety (12–14). Capitalizing on the or-
thogonality and specificity of its G protein–coupled receptor (GPCR)
mating pathway (15), it has also shown potential as a platform for drug
discovery by engineering mammalian GPCRs (16, 17).
To overcome current bottlenecks in deployment of biosensors, we
developed a modular, single-component biosensor that uses fungalmating GPCRs for detection of pathogen-specific peptides and a red
plant pigment as readout (Fig. 1). Expanding on well-established
methods for scalable and cost-effective distribution of S. cerevisiae, we
envision that this portable, safe biosensor can enable routine on-site
pathogen surveillance.
We demonstrate the utility of our platform for detection of fungal
pathogens, a rising global public health burden particularly acute in
developing countries (2, 18, 19). Fungal pathogens cause an estimated
2 million deaths annually and inflict devastating losses of plant crops
and population decline in animal wildlife (2, 19). However, efforts to
abate fungal infections prevalent in resource-limited areas are ham-
pered by the dearth of fungal diagnostics (20). We thus used the large
reservoir of natural fungal GPCRs to construct S. cerevisiae–based bio-
sensors for detection of fungi responsible for major human disease, ag-
ricultural damage, and food spoilage.RESULTS
S. cerevisiae as a biosensor visible to the naked eye
We started by building a prototype biosensor for detection of Candida
albicans, a commensal human pathogen and the leading cause of life-
threatening infections in immunocompromised patients (18).C. albicans
is among the most genetically tractable pathogenic fungi, with a well-
studiedmating system (21). For specific detection of theC. albicansmating
peptide, we replaced the S. cerevisiae mating receptor (Sc.Ste2) with
that ofC. albicans (Ca.Ste2) (tables S1 and S2).We then used synthetic
C. albicans mating pheromone to test receptor activation using a fluo-
rescent reporter that is induced by the mating signaling pathway (17).
Consistent with previous reports (22), we found Ca.Ste2 to be highly
sensitive to its cognate ligand, with an EC50 value (concentration of pep-
tide required for half-maximal activation) of ~4 nM (Fig. 2A). To probe
receptor specificity further, we also tested Ca.Ste2 activation using nine
heterologous fungalmating peptides and found it to be highly specific to
its mating peptide (Fig. 2B).
Tomeet the needs of on-site detection, we then replaced the fluores-
cent readout with a robust signal that is easily visible to the naked eye.
We chose lycopene, an antioxidant carotenoid pigment naturally
produced inplants andbacteria andwidely used formetabolic engineer-
ing (23). We introduced the lycopene production pathway into our
strain by placing the first two biosynthetic genes, Erwinia herbicola crtE1 of 9
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nloaFig. 1. S. cerevisiae biosensor for detection of fungal pathogens. (A) Overview of biosensor components. Highly specific fungal receptors provide sensitive response to
mating peptides secreted by pathogenic fungi. Activation of the downstreammating signaling pathway induces transcriptional activation of biosynthetic genes for production of
red lycopenepigment visible to the naked eye. FMN, flavinmononucleotide; FAD, flavin adeninedinucleotide; FPP, farnesyl pyrophosphate; GGPP, geranylgeranyl pyrophosphate.





Fig. 2. Biosensor functionality and lycopene optimization. (A) Activation of C. albicansmating receptor (Ca.Ste2) in S. cerevisiae by its cognatemating peptide. Fluorescence
(black) and lycopene absorbance (red)were used as a transcriptional readout for receptor activation. (B) Specificity of Ca.Ste2 and Sc.Ste2 receptors. Fluorescencewas determined
after 9 hours using 5 mM synthetic fungal peptides. (C) Optimization of lycopene production. Maximal lycopene yield wasmeasured after inductionwith 10 mM synthetic S. cerevisiae
mating peptide. Null, parental strain (no lycopene genes); Lyco-1, parental strain with single-copy CrtE, CrtB, and CrtI; 2xCrtI, Lyco-1 with additional plasmid-borne copy of CrtI;
Fad1, Lyco-1 with additional plasmid-borne copy of Fad1; Lyco-2, all genes genomically integrated into Lyco-1. (D) Time course of lycopene production in lycopene-
producing strains. Induction as in (C). (E) Representative photos of cell pellets (5 × 107 cells) corresponding to strains in (D). Lycopene per cell was determined by spectroscopy
(see Supplementary Methods).Ostrov et al., Sci. Adv. 2017;3 : e1603221 28 June 2017 2 of 9
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(geranylgeranyl diphosphate synthase) and crtB (phytoene synthase),
under constitutive promoters from ADH1 and TEF1, respectively.
To tie lycopene production to activation of the mating receptor, we
placed the last pathway gene crtI (lycopene synthase) under control
of the pheromone-inducible promoter from FUS1 (Fig. 1 and fig. S1).
To circumvent the low-throughput chemical extraction that is tra-
ditionally used for measurement of lycopene yield (23), we developed a
quantitative absorbance-basedmethod tomeasure lycopene production
per cell (LPC) (Supplementary Methods). We determined ≥3.5 LPC
units to be a stringent threshold for a robust yes/no lycopene readout
visible to the naked eye.
Lycopene production in this initial strain reached a maximum of
3 LPC units, just below the visible threshold (Fig. 2, C to E). We thus
optimized lycopene production by adding another copy of the en-
dogenous flavin adenine dinucleotide synthase (FAD1) (24) and ly-
copene synthase (crtI) (fig. S1). The enhanced strain exhibited strong
lycopene production of more than 10 LPC units, crossing the visible
lycopene threshold in only 3 hours (Fig. 2, D and E).
Using the lycopene readout, we measured the limit of detection
(LoD) of our C. albicans biosensor in liquid culture to be 1 to 10 nM
mating peptide, with lycopene sensitivity closely matching that of the
fluorescent reporter (Fig. 2A). The LoD and strong lycopene readout
remained stable across pH and temperature and in clinically relevant
samples such as urine and serum (fig. S2). Together, these results estab-
lish the feasibility of using S. cerevisiae as a specific and sensitive detec-
tor, competitive with culture-based diagnostic methods.
Fungal GPCRs as modular detection elements for invasive
fungal pathogens
Next, we sought to expand the range of target pathogens.However, con-
trary to C. albicans, the mating systems for most fungal pathogens are
not well studied (25). To identify candidate mating receptors, we
searched the large reservoir of available fungal genomes for receptors
and putative mating peptides homologous to S. cerevisiae STE2 and
MFa1, respectively (table S1 and fig. S3A) (26). We introduced codon-
optimized or wild-type receptor genes into an S. cerevisiae strain
containing a fluorescent reporter (yMJ183) and measured receptor ac-
tivation using the cognate fungal mating peptides (Fig. 3A, fig. S4, and
table S2).
By simply swapping the Ste2 receptor, we generated functional bio-
sensors for 10 major human, agricultural, and food spoilage pathogens:
Candida albicans, Candida glabrata, Paracoccidioides brasiliensis,
Histoplasma capsulatum, Lodderomyces elongisporus, Botrytis cinerea,
Fusarium graminearum,Magnaporthe oryzae, Zygosaccharomyces bailii,
and Zygosaccharomyces rouxii. Notably, no additional engineering was
necessary for activation of these heterologous receptors, as is often re-
quired for mammalian GPCRs, possibly due to higher homology with
the endogenous receptor (fig. S3).
All receptors exhibited high sensitivity to their cognate ligands, with
EC50 values ranging from 14 mM to 4 nM (Fig. 3B and fig. S4). Codon
optimization of the receptor gene provided a slight increase in sensitiv-
ity (fig. S4B).
Most tested receptors were also highly specific to their cognate mat-
ing peptide, as expected formediators of species-specific signals (Fig. 3C
and fig. S5). Notably, our results showdifferential detection ofC. albicans,
C. glabrata, L. elongisporus, and P. brasiliensis, major human pathogens
with distinct susceptibility to antifungal drugs (27).
We then turned to implementing our lycopene readout for these new
fungal targets. Comparison of the fluorescent activation profile of theseOstrov et al., Sci. Adv. 2017;3 : e1603221 28 June 2017biosensors with that of our initial C. albicans biosensor suggested that
the new set of receptors could be readily implemented with the opti-
mized lycopene readout strain to give a strong readout visible to the
naked eye (Figs. 2A and 3A).We chose the biosensor for P. brasiliensis
for further characterization. As with the C. albicans biosensor, we ob-
served a P. brasiliensis pheromone LoD of <0.01 to 10 nM and a 3.9 ±
0.1 fold activation of lycopene production, yielding a robust readout
across pH and temperature and in urine and serum (fig. S6).
Detection of fungal pathogen clinical isolates
Next, we challenged our biosensor for detection of naturally secreted
mating peptides using clinically isolated Paracoccidioides strains. Para-
coccidioidomycosis (PCM), an invasive fungal infection endemic to
Latin America, is one of many neglected tropical diseases that primarily
affect poor populations and lack systematic surveillance (28). PCM is
caused by inhalation of airborne conidia produced by mycelium of
the soil ascomycete P. brasiliensis (29). Recent identification of the ge-
netic components underlying its mating system (30) enabled us to pur-
sue specific yeast-based detection ofP. brasiliensis, which could facilitate
detection of its environmental reservoir.
Specifically, we challenged our biosensor to detect cultured mycelial
P. brasiliensis isolated from human patients (see Materials and
Methods). Biosensor cells expressing P. brasiliensis mating receptor,
which exhibited specific and sensitive detection of its synthetic mating
peptide (figs. S5A and S6), were mixed with spent supernatants from
two clinically isolated Paracoccidioides strains (table S2). In response,
we observed lycopene production well above the visible threshold
(Fig. 3E). Secretedmating peptides were similarly detected from clinical
isolates of C. albicans and H. capsulatum (Fig. 3E). The peptide
produced by H. capsulatum (30), the causative agent of histoplasmosis
(18), is identical to that of P. brasiliensis and could be detected using
both biosensor strains (fig. S7).
A low-cost, low-tech dipstick assay
Encouraged by these results, we then focused our efforts toward
translation of our assay to the field by developing a simple dipstick test.
For this aim, biosensor and control cells were spotted onto filter paper,
and detection was performed by simply dipping the paper into liquid
samples containing synthetic mating peptides (Fig. 4A and fig. S8). In
addition to visual inspection, we quantified lycopene accumulation on
paper using pixel color analysis (Supplementary Methods).
Using aP. brasiliensisdipstick assay, we observed a robust and highly
reproducible signal that surpassed the visible lycopene threshold to give
a clear yes/no readout (Fig. 4B and movie S1). Similar results were
achieved using a C. albicans dipstick assay (Fig. 4C and fig. S9). As
expected, no cross-reactivity was observed between these two pathogens
(movie S1). Last, to ensure that the signal remains visible in complex
samples, we performed dipstick tests in soil, urine, serum, and blood
supplemented with synthetic mating peptides. In all sample types, mi-
cromolar levels of peptide were successfully detected (Fig. 4D, fig. S9,
and movies S2 to S5). The dipstick assay retained its functionality after
being stored for 38 weeks at room temperature (fig. S10).DISCUSSION
In summary, our results show the feasibility and robustness of pathogen
detection using engineered S. cerevisiae. We achieved sensitivity and
specificity levels comparable to those ofmammalian,whole-cell, antibody,
and nucleic acid assays, all of which are significantly more expensive3 of 9
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and technically demanding. Our assay can be constructed cheaply on a
large scale by leveraging existing infrastructure for yeast culture, widely
distributed as a stable dried product for household use, robustly applied
to complex samples, and readily detected by eye.
Although the lycopene readout already provides a robust yes/no re-
sponse, that response can be further enhanced through promoter opti-
mization, signal amplification feedback loops, alternate lycopene
biosynthetic enzymes, or engineering of receptor/G protein interaction.
Additionally, although theGPCRs already showmarked specificity, total
assay specificity can be increased by incorporating additional positive
and negative biosensor spots for other target and off-target pheromones
or by engineering the pheromone specificity of individual receptors.Ostrov et al., Sci. Adv. 2017;3 : e1603221 28 June 2017Fungal pheromones represent a promising class of species-specific
biomarkers that may be used to overcome the time-consuming
methods in place today for the definitive diagnosis of fungal pathogens
(3, 18). The biosensors developed in this work will simplify the valida-
tion of these peptide biomarkers, which remain poorly characterized in
clinical and environmental samples (31). While at an early stage of im-
plementation, these biosensors can be immediately adopted in the clinic
to shorten the time required for diagnosis of fungal pathogens from
blood cultures (see Supplementary Methods). Furthermore, pathogen
characterization can be expanded to other fungi by adding new
GPCR-pheromone pairs, identified through fungal genome mining,
to our biosensor platform.Fig. 3. Yeast biosensor for multiple fungal peptides. (A) Activation of fungal mating receptors in S. cerevisiae by the corresponding cognate synthetic mating
peptides (40 mM) (see also fig. S4). Dotted line denotes the effective visible threshold from Fig. 2A. (B) EC50 values calculated for fungal receptors in S. cerevisiae using
cognate ligands. (C) Specificity of heterologous fungal receptors. Receptors were activated by 5 mM synthetic peptides. Response was measured by fluorescence and
normalized for each receptor (see fig. S5). (D) Comparative scoring of all biosensors. (E) Lycopene production induced by culture supernatant from clinically isolated
fungal pathogens. Lycopene per cell measured by spectroscopy at 9 hours (see Supplementary Methods). **P ≤ 0.01, ***P ≤ 0.001; n = 3.4 of 9
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The range of biosensor targets can be further extended beyond fun-
gal pheromones by leveraging established GPCR-directed evolution
methods in yeast (16, 17). Fungal GPCRs, as well as other GPCR classes,
can be engineered to recognize novel peptide, protein, polysaccharide,
and small-molecule ligands as potential targets for yeast-based detection
of bacteria, viruses, toxins, and other diseases.
Although early success has established the impact of synthetic bi-
ology in the field ofmetabolic engineering, the application of synthetic
biology to grand challenges in biomedicine, materials science, and
other fields is still at an early stage of development. Here, we show
that yeast engineered with the growing toolbox of synthetic biology can
have a major impact on the field of biosensors. While sophisticated,
highly technical diagnostics remain limited to clinical and industrial
laboratories, reliable low-tech tools accessible to the general population
can provide disruptive cheap alternatives to broadly transform the field
of diagnostics.MATERIALS AND METHODS
Materials
Synthetic mating peptides (≥95% purity) were obtained from GenScript
or Zymo Research. Polymerases, restriction enzymes, and Gibson
assemblymixwere obtained fromNewEnglandBiolabs. CulturemediumOstrov et al., Sci. Adv. 2017;3 : e1603221 28 June 2017components were obtained from BD Bioscience and Sigma-Aldrich.
Primers and syntheticDNAwere purchased from IntegratedDNATech-
nologies (IDT). Plasmids were cloned and amplified in either Escherichia
coli TG1 or C3040 (New England Biolabs). Human urine (catalog no.
IR100007P) and single donor human whole blood (catalog no. IPLA-
WB1) were purchased from Innovative Research. Human serum,
normal off the clot (frozen) (catalog no. HSER-2ML) was purchased
fromZen-Bio. Professional pottingmix soil was purchased fromFafard.
S. cerevisiae general cloning methods
All strains were derived from parental reiterative recombination ac-
ceptor strain LW2591 (MATa-inc genotype), and cloning of expres-
sion modules into the HO locus was performed using reiterative
recombination (32). Scarless gene deletions and gene replacements
were carried out using delitto perfetto (33). Endogenous yeast promo-
ters, terminators, and open reading frames (ORFs) were obtained by
polymerase chain reaction (PCR) from strain FY251 [American Type
Culture Collection (ATCC) 96098] or LW2591 (32). Yeast transfor-
mations were carried out using the lithium acetate method (34). All
plasmids are derivatives of the pRS41x series of centromeric shuttle
plasmids, and were cloned using standard molecular biology protocols
and Gibson assembly (35). Yeast strains used in this study are listed in
table S2. Plasmids used in this study are listed in table S3. ExpressionFig. 4. Paper-baseddipstick assay fordetectionof fungal pathogens. (A)Dipstickdevice. Inset: “+,”positivebiosensor strain; “−,”negative control strain. (B)Quantitativeanalysisof
lycopeneproductionusingdipstick assay, as scoredby time-lapsephotography (seeSupplementaryMethods) fordetectionof1mMsyntheticP. brasiliensismatingpeptide. Individual runs
are shown in light color, and average response is shown in dark color. Shading indicates visible threshold. (C) P. brasiliensis and C. albicansmating peptides were reproducibly detected
using the dipstick assay.Maximal responsewas achieved by 12 hours after exposure to the respective peptides (1 mM). (D) Detection of P. brasiliensismatingpeptide in complex samples.
Liquid sampleswere supplementedwith syntheticP. brasiliensismatingpeptide (blue) orwater (gray), and scoredas in (B). YPD,mediumonly; soil, standardpotting soil; urine, 50%pooled
human urine; serum, 50% human serum; blood, 2% whole blood. All experiments were performed using 1 mM peptide and supplemented with YPD medium. AU, arbitrary units.5 of 9
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modules constructed in this study are listed in table S4. Primers used for
cloning receptors from genomic DNA and plasmid pLPreB are listed in
table S5. Codon-optimized and native receptor ORFs used in this study
are listed in table S6.
Determination of fungal GPCRs andmating peptides sequences
Fungal receptors were derived from pathogenic fungi selected from
the PFAM (36) family PF02116. Sequences were validated bymultiple
sequence alignment using MUSCLE (37), ranging from 21 to 49%
identity towild-type S. cerevisiae Ste2. The corresponding peptide ligands
were taken from Martin et al. (26) for species B. cinerea, M. oryzae,
F. graminearum, C. glabrata, C. albicans, L. elongisporus, and Z. rouxii.
The peptide ligand common to species P. brasiliensis andH. capsulatum
was taken from Gomes-Rezende et al. (30). The peptide ligand for spe-
cies Z. bailii was predicted using the method reported by Martin et al.
(26). TheUniProtKB accession numbers for all receptors and sequences
of fungal peptides are listed in table S1.
Cloning of fungal GPCRs
As detailed in table S1, somemating receptor ORFs were synthesized as
codon-optimized genes for S. cerevisiae (see table S6), and others were
cloned directly from the appropriate fungal genomic DNA (ATCC) or
plasmid pLPreB using primers in table S5. Codon optimizationwas per-
formed with the JCat Codon Adaptation tool (38) using the default set-
ting for S. cerevisiae and further optimized for cloning with the IDT
codon optimization tool (Integrated DNA Technologies). All recep-
tor ORFs were incorporated into expression modules containing the
S. cerevisiae TDH3 promoter and STE2 terminator (see table S4). For
fluorescent assays using reporter strain yMJ183, receptor expression
modules were cloned into low-copy plasmids derived from pRS416
(table S3). For lycopene biosensor strains, receptor expression mod-
ules were integrated at the STE2 locus.
Cloning of fluorescent reporter strain
A codon-optimized copy of the mCherry fluorescent reporter gene (39)
was cloned with the S. cerevisiae pheromone-inducible FUS1 promoter
andACT1 terminator (table S4). This expressionmodule was integrated
at the reiterative recombination acceptor site in strain yMJ105. The STE2
gene was deleted to yield the fluorescent reporter strain yMJ183. Geno-
types of all strains are listed in table S2.
Cloning of lycopene biosensor strains
The parent lycopene biosensor strain (Lyco-1; yMJ118)was constructed
by cloning of lycopene pathway genes fromE. herbicola at the reiterative
recombination acceptor site in strain yMJ105. The crtE, crtB, and crtI
ORFs were obtained from plasmid pSC203 (a generous gift from
G. Stephanopolous at MIT) (40). The crtE (geranylgeranyl diphosphate
synthase) and crtB (phytoene synthase) ORFs were cloned into a constitu-
tive expressionmodule containingpromoters fromTEF1andPGK1and the
bidirectional terminator from ADH1. The crtI (lycopene synthase) ORF
was cloned into a pheromone-inducible expression module containing
the promoter from FUS1 and the terminator from ACT1. The enhanced
parent lycopene biosensor strain (Lyco-2; yMJ251) carried an additional
copyof thepFUS1-CrtI-tACT1expressionmodule integratedat theMET15
locus and a pTDH3-FAD1-tCYC1overexpressionmodule integrated at the
reiterative recombination acceptor site. All fungal biosensor strains de-
scribed in this study were derived from yMJ251 by replacement of the en-
dogenous STE2 gene with the appropriate fungal receptor expression
module (table S4). Genotypes of all strains are listed in table S2.Ostrov et al., Sci. Adv. 2017;3 : e1603221 28 June 2017Characterization of GPCR activation in S. cerevisiae
Fungal mating receptor Ste2 activity was measured in strain yMJ183
using the fluorescent reporter mCherry. The fluorescent reporter strains
carrying the appropriate fungal Ste2 expression plasmid were assayed in
96-wellmicrotiter plates cultured at 30°Cand800 rpm.Cellswere seeded
at an optical density at 600 nm (OD600) of 1 in standard synthetic
dropout medium (2% dextrose) lacking the appropriate selective
component with either synthetic fungal mating peptide or water (con-
trol) as indicated. All measurements were performed in triplicate.
mCherry fluorescence (excitation, 588 nm; emission, 620 nm) and
culture turbidity (OD600) were measured using an Infinite M200 plate
reader (Tecan). TheOD600 valuewas correctedusing eq. S6 (Supplemen-
tary Methods). To determine EC50 and fold activation values, the fluo-
rescence response of strain yMJ183 carrying the appropriate Ste2
receptor was measured at different concentrations of the appropriate
synthetic mating peptide. All raw fluorescence values were normalized
by the OD600 and plotted against the corresponding peptide concentra-
tion, and the points fit with a four-parameter logistic curve using Prism
(GraphPad). Fold activationwas calculated for each receptor strain as the
maximum OD600-normalized fluorescence of peptide-treated cells
divided by the OD600-normalized fluorescence value of water-treated
cells. For cross-reactivitymeasurements, receptor activationwas individ-
uallymeasuredusing eachof the synthetic fungalmatingpeptides (5mM).
Percent receptor activationwas calculated by setting theOD600-normalized
fluorescence value of cognate-peptide activation to 100% and the value
of water-treated cells to 0% (see gray regions in fig. S5A).
Characterization of the lycopene readout in liquid culture
Induction of lycopene was assayed using strain yMJ118 or yMJ251 in
96-well microtiter plates cultured at 30°C and 800 rpm. Cells were
seeded at an OD600 of 2 in standard complete synthetic medium (2%
dextrose) supplemented with 5% yeast extract peptone dextrose (YPD)
medium and with the indicated concentration of synthetic peptide. All
measurements were performed in triplicate. Cell density and medium
conditions were chosen to more closely mimic conditions relevant for
the yeast-based paper assay (that is, high cell density and nonselective
complex medium) while enabling more precise spectroscopic determi-
nation of lycopene content (that is, higher bulk signal at early time
points and low-absorbance medium). Under these conditions, the
cultures grew to a maximal OD600 of 6. Relative lycopene content was
calculated by spectroscopy (41) using eq. S5 (SupplementaryMethods).
Optical densities were measured with an Infinite M200 plate reader
(Tecan). Lycopene values were normalized by the culture OD600 to give
a measure of lycopene per cell. For each strain, maximum yield of
lycopene per OD600 was determined as the largest observed value
over a 72-hour period for each biological replicate. Half-maximal lyco-
pene per cell for each biological replicate was calculated as the aver-
age of the largest and smallest lycopene per OD600 value observed
over a 72-hour period. Time to half-maximal lycopene per cell for
each strainwas determined by linear interpolation between the two time
points with lycopene per OD600 values that spanned the calculated half-
maximal lycopene per OD600 for each biological replicate.
Characterization of biosensor strains in liquid culture
(pH, temperature, and complex samples)
P. brasiliensis or C. albicans biosensor strains (yMJ258 and yMJ260, re-
spectively) were characterized in 96-well microtiter plates cultured at
800 rpm. Cells were seeded at an OD600 of 2 in standard complete syn-
theticmedium (2%dextrose) supplemented with 5%YPDmedium and6 of 9
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the indicated concentration of synthetic peptide. A 2× stock of medi-
um and a 10× stock of the ligandwere diluted to reach the appropriate
1× concentration. All measurements were performed in triplicate
(figs. S2 and S6). Lycopene production was measured by absorbance
as described above. For temperature assays, themicrotiter plate shaker
was preequalized to the appropriate temperature for 1 hour before the
start of the assay. For pHassays, the pHof themediumstockwas titrated
to the appropriate value with sodium hydroxide. For complex sample
assays, urine and serum were centrifuged to remove particulates and
used at a final concentration of 50% (in 1× YPD). The LoDwas defined
as the lowest experimentally determined peptide concentration giving a
lycopene signal significantly above the water-treated sample (P≤ 0.01).
P values were determined by performing a paired parametric t test com-
paring peptide- and water-treated samples in Prism (GraphPad).
Preparation of culture supernatant from clinically isolated
fungal pathogens
H. capsulatum
Supernatants from strains Hc01 and Hc06 were a gift from C. Rappleye
(Department of Microbiology, Ohio State University, Columbus,
OH). These strains are clinical isolates representing North America
class 2 (NAm2) and North America class 1 (NAm1), respectively (42).
H. capsulatum strains were added to liquid sabouraud dextrose agar
medium [glucose (40 g/liter) and peptone (10 g/liter)] at 105 cells/ml
and incubated for 10 days at 26°C without agitation to induce con-
version to mycelia. Conversion to mycelia was confirmed by phase-
contrast microscopy. Mycelia were then transferred to Histoplasma
macrophage medium (43), and the cultures were incubated at 26°C.
After 3 weeks of growth, mycelia were separated from the super-
natant by filtration through a cellulose filter (Whatman qualitative
filter paper #2, 8-mm-diameter pores) and the filtrate was subse-
quently filtered through a polyethersulfone membrane (0.45-mm-
diameter pores) to obtain the final culture filtrate. The supernatants
were lyophilized, resuspended in 0.1 volume of H2O (10× concentra-
tion), and kept at −20°C.
Paracoccidioides spp.
Supernatants from P. brasiliensis Pb18 and Paracoccidioides lutzii Pb01
cultures were a gift from F. Rodrigues [Life and Health Sciences Re-
search Institute (ICVS), University of Minho, Braga, Portugal]. These
strains are clinical isolates containing mating loci MAT1-2 and
MAT1-1, respectively (44). The mycelium form was grown at 24°C at
150 rpm in synthetic McVeigh-Morton liquid medium (45). Superna-
tants were collected by filtration 10 days after the yeast-mycelium
transition. The supernatants were lyophilized, resuspended in 0.1 vol-
ume of H2O (10× concentration), and kept at −20°C.
C. albicans
Human isolateGC75withMTLa/MTLa (46) was a gift fromR. Bennett
(Department of Molecular Microbiology and Immunology, Brown
University, Providence, RI). A second human isolate of C. albicans
was provided by A.-C. Uhlemann (Department of Medicine, Division
of Infectious Diseases, Columbia University, New York, NY). This iso-
late, referred to as ySB36, was genotyped by PCR for its mating loci
using genomicDNAas template as previously described (47) and found
to be heterozygous for its mating loci, MTLa/MTLa (for primers, see
table S5). Homozygous MTLa/MTLa derivatives of ySB36 were ob-
tained by selection on sorbose, as previously described (48). In brief,
ySB36 was cultured for 16 hours in YPD liquid medium at 30°C and
washed once with water, and ~105 cells were plated on 2% sorbose me-
dium (0.67% yeast nitrogen base without amino acids, 2% sorbose). Co-Ostrov et al., Sci. Adv. 2017;3 : e1603221 28 June 2017lonies were visible after 4 days of incubation at 30°C. Several colonies
were restreaked on 2% sorbose medium, followed by restreaking on
YPD medium and genotyping by colony PCR as above. One homozy-
gous MTLa/MTLa isolate (ySB45) was used for supernatant prepara-
tion. Phenotypically switched opaque colonies of GC75 and ySB45were
isolated by phloxine B staining, as previously described (49). In brief, a
single colony of GC75 or ySB45 was incubated for 24 hours at 25°C in
liquidYPDmediumwithout agitation. In total, ~2× 103 cells were plated
on YPD agar supplemented with phloxine B (5 mg/ml; Sigma-Aldrich)
and incubated at 25°C for 4 days. Opaque colonies stained pink on
phloxine B–containingmedium. For supernatant preparation, a single
opaque colony ofC. albicansGC75or ySB45was cultured overnight in
YPD medium at 25°C and used to inoculate 50 ml of YPD liquid me-
dium. Cells were cultured for ~24 hours at 25°C to a final OD600 of 9.5
(~2.8 × 108 cells/ml) and 7.9 (~2.3 × 108 cells/ml). Cells were pelleted
by centrifugation, and the supernatant was reduced to dryness by vac-
uum concentration, resuspended in 0.1 volume H2O (10× concentra-
tion), and kept at −20°C.
S. cerevisiae
Samples were obtained from S. cerevisiae strain FY250 withMTLa (50)
andW303-1BwithMTLa (ATCC201238). Cellswere cultured in 50ml
of YPD medium for 20 hours at 30°C to a final OD600 of 9.8 (~2.9 ×
108 cells/ml) and 8.5 (~2.5 × 108 cells/ml), respectively. Cells were pel-
leted by centrifugation, and the supernatant of FY250 was reduced to
dryness by vacuum concentration, resuspended in 0.1 volume H2O
(10× concentration), and kept at −20°C. The supernatant of W303-
1B was kept at 1× concentration at −20°C.
Detection of mating peptides in supernatants of clinically
isolated fungal strains
P. brasiliensis or C. albicans biosensor strains (yMJ258 and yMJ260, re-
spectively) and a control S. cerevisiae strain (yMJ251) were used to test
for the presence of the respective mating peptides in supernatants
derived from clinically isolated pathogenic fungi or S. cerevisiae (super-
natant preparation described above). Cells were seeded at anOD600 of 2
in the indicated supernatant mixed with standard complete synthetic
medium (2% dextrose) supplemented with 5% YPD in 96-well micro-
titer plates and cultured at 30°C and 800 rpm, and lycopene production
wasmeasured by absorbance as described above. A 2× stock ofmedium
and a 10× stock of the supernatant were used and diluted to reach the
appropriate 1× concentration. The control supernatant for W303-1B
was diluted to 50% in the final assay. Statistical significance of signal
(that is, biosensor strain treatedwith its cognate supernatant) over noise
(same biosensor strain treated with noncognate supernatants) was de-
termined by performing a paired parametric t test in Prism (GraphPad).
The highest P value resulting from sample comparisons is given as
**P≤ 0.01 and ***P≤ 0.001 (Fig. 3E). Allmeasurementswere performed
in triplicate.
Paper-based dipstick assay for detection of fungal peptides
in complex samples
A simple, low-cost dipstick assay was designed with the biosensor
strains spotted on paper as the only required active component (fig.
S8). To assemble the dipstick, the biosensor strains were precultured
in 50 ml of YPDmedium at 30°C at 300 rpm for 72 hours. The culture
was diluted with water to an OD600 of 2.5 and vacuum-filtered onto a
glass fiber filter paper (Thermo Scientific, DS0281-7500) using a plastic
stencil to generate spots with a diameter of 5 mm. An appropriate
culture volume was used to give about 5 × 107 cells per spot. The filter7 of 9
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paper with biosensor spots was cut into small squares (8 mm × 8 mm,
one biosensor spot) and placed onto a strip of wicking paper made of a
standard brown paper towel (fig. S8, B and C). Each paper-based
dipstick assay contained two different spots, an indicator (biosensor)
spot and a control spot composed of S. cerevisiae carrying an off-target
receptor as a negative control (fig. S8B).
To characterize its functionality, the dipstick was dipped into 1ml of
liquid sample and incubated at 30°C. The lycopene readout was visually
inspected and quantitatively measured using time-lapse photography
analyzed with ImageJ (see Supplementary Methods) (51). A 24-well
plate was used to easily array several dipsticks in the field of view of
the camera. For all assays, a 10× stock of medium was used and diluted
to reach the appropriate 1× concentration. All measurements were per-
formed in three or more replicates. For YPD assays (Fig. 4, B to D, fig.
S9, and movie S1), the dipstick was dipped into 1× YPD medium sup-
plemented with 1 mMof the indicated fungal pathogen peptide. For soil
assays (Fig. 4D, fig. S9B, andmovie S2), 0.5 g of soil was preconditioned
with 2 nmol (in 200 ml of water) of the indicated fungal pathogen pep-
tide and allowed to air-dry for 1 hour. The dipstick was inserted into the
soil and 2 ml of 1× YPD medium was added to give a concentration of
1 mM fungal peptide. For urine and serum assays (Fig. 4D, fig. S9B, and
movies S3 and S4), the samples were vortexed briefly to resuspend par-
ticles and supplemented with 1× YPDmedium to give a concentration
of 50% of urine or serum. For blood assays (Fig. 4D, fig. S9B, andmovie
S5), the sample was supplemented with 1× YPDmedium to give a final
concentration of 2% blood.
Additionally, we designed a small plastic holder to facilitate the
ease of use of this dipstick assay (fig. S8D). This plastic holder was three-
dimensionally (3D) printed out of acrylonitrile butadiene styrene. We
validated that the holder did not negatively affect the assay functionality
(fig. S8E).
Long-term stability of the paper-based dipstick
To assay the long-term stability of the paper dipstick, the biosensor
spots were prepared on filter paper as described above and allowed to
air-dry for 20 min at room temperature. The filter papers were then
placed in plastic pouches, flushed with argon, sealed, and stored in
the dark at room temperature. After 38 weeks of storage, the filter
papers were removed from the storage pouches and assembled with
the paper towel wicking paper as described above. To characterize their
functionality, the assembled paper dipsticks were rehydrated by dipping
them directly into 1 ml of liquid sample composed of 1× YPDmedium
supplemented with either 1 mM of the indicated fungal pathogen pep-
tide or water as a control and incubated at 30°C. The lycopene readout
was visually inspected and quantitatively measured using time-lapse
photography (see Supplementary Methods). All measurements were
performed in three or more replicates.
Visibility threshold of lycopene readout
When measured spectroscopically (see Supplementary Methods), we
determined a visible threshold of 3.5 LPC in liquid cultures. This thresh-
old was determined by visually inspecting pellets of 5 × 107 cells as
shown in Fig. 2E. This visible threshold is noted by the gray line in Figs.
2 (A, C, and D) and 3E and figs. S1, S2, and S6.We also determined the
corresponding effective visibility threshold for receptors characterized
via fluorescent reporters to be 120 fluorescent units per cell, by compar-
ing the lycopene and fluorescent readouts as shown in dose-response
curves for the C. albicans biosensor (Fig. 2A). This effective visibility
threshold is shown by the dotted line in Fig. 3A.Ostrov et al., Sci. Adv. 2017;3 : e1603221 28 June 2017We also determined a visibility threshold for paper-based dipstick
assay when measured by time-lapse photography and pixel color anal-
ysis (see SupplementaryMethods). This was done by visually inspecting
time-lapse clips as shown in movie S1. The visible threshold for the
dipstick assay was determined to be 4 D red color units and is shown
by a gray line in Fig. 4 (B and D) and figs. S8E and S9.SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/3/6/e1603221/DC1
Supplementary Methods
fig. S1. Optimization of peptide-induced lycopene production.
fig. S2. C. albicans biosensor robustness in liquid culture.
fig. S3. Sequence analysis of fungal mating receptors.
fig. S4. Dose-response curves for fungal mating receptors.
fig. S5. Specificity of fungal mating receptors.
fig. S6. P. brasiliensis biosensor characterization in liquid culture.
fig. S7. Comparison of mating receptors from human pathogens P. brasiliensis and H. capsulatum.
fig. S8. Paper-based dipstick assay.
fig. S9. Detection of C. albicans using dipstick assay.
fig. S10. Long-term stability of paper-based dipsticks stored at room temperature.
table S1. Fungal pathogen peptides and receptor genes used in this study.
table S2. Strains used in this study.
table S3. Plasmids used in this study.
table S4. List of expression modules constructed in this study.
table S5. Primers for cloning of fungal receptors and for genotyping of C. albicans isolates.
table S6. DNA sequence for fungal receptor ORFs used in this study.
movie S1. Yeast dipstick assay with plastic holder.
movie S2. Yeast dipstick assay in soil.
movie S3. Yeast dipstick assay in urine.
movie S4. Yeast dipstick assay in serum.
movie S5. Yeast dipstick assay in blood.
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